Benzinga | Jul 16, 2020 07:02AM EDT

Abiomed Announces FDA Approval Of Data Streaming From Co.'s Automated Impella Controller

The United States Food and Drug Administration (FDA) has approved one-way digital data streaming during patient support from Abiomed's (NASDAQ:ABMD) Automated Impella Controller (AIC), the external console used with Impella heart pumps. The data streaming capability is facilitated through the Impella Connect interface, a HIPAA-compliant, cloud-based remote monitoring platform that is currently installed at more than 200 hospitals. The approval means console data could be streamed live via Impella Connect to a secure server where artificial intelligence (AI) could provide predictive clinical information to the patient's physician.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200716005318/en/